title: Lactoferrin, a glycoprotein with immunomodulatory and mast cell stabilising properties, in skin of horses suffering from Culicoides hypersensitivity.
abstract: Lactoferrin (LF), a glycogen of the transferrin family with anti-bacterial and immunomodulatory properties, is expressed in various secretions and tissues. Cutaneous LF serves as a mast cell stabilising compound, modulates T cell activity and is found during IgE-mediated late phase reactions at allergen challenged sites. Culicoides hypersensitivity (CHS) in horses is a common IgE-mediated allergic dermatitis, characterised by an early and late phase cutaneous reaction upon allergen challenge. The aim of the study presented here was to examine whether LF mRNA expression in skin biopsies from horses affected by CHS prior to and 4h following intradermal challenge with a commercial C. nubeculosus extract is modified in comparison to skin biopsies from non-affected horses. In order to obtain reliable data, real time PCR was performed and genes of interest were normalized using three different housekeeping genes, beta-actin, GAPDH, beta-2-microglobulin. In comparison to non-affected horses, higher variation in LF mRNA levels both prior to and post-intradermal challenge with C. nubeculosus extract was seen in horses affected by CHS. However, the statistical analysis demonstrated that LF mRNA expression was not significantly different between CHS affected and non-affected horses prior to intradermal challenge with C. nubeculosus extract. Intradermal injection of C. nubeculosus extract did not result in local upregulation of LF mRNA at 4h post-injection. LF mRNA expression was therefore not significantly different pre- or post-intradermal challenge with C. nubeculosus extract in either group. Our data indicate that clinically normal skin of horses affected by CHS is not characterized by modified maintenance levels of LF mRNA. In contrast to human skin allergen challenged sites, LF mRNA levels in horses affected by CHS are not significantly different to that of control sites at 4h post-injection of C. nubeculosus extract.
authors.affiliation: Department for Animal Breeding and Reproduction, University of Veterinary Medicine Vienna, Veterinaerplatz 1, A-1210 Vienna, Austria. gabriela.kolm@vu-wien.ac.at
authors.forename: Gabriela
authors.initials: G
authors.lastname: Kolm
authors.forename: Elzbieta
authors.initials: E
authors.lastname: Knapp
authors.forename: Regina
authors.initials: R
authors.lastname: Wagner
authors.forename: Dieter
authors.initials: D
authors.lastname: Klein
mesh_terms: D000818:Animals; D002519:Ceratopogonidae / Q000276:immunology*; D006734:Horse Diseases / Q000276:immunology / Q000378:metabolism*; D006736:Horses; D006967:Hypersensitivity / Q000276:immunology / Q000378:metabolism / Q000662:veterinary*; D007299:Insect Bites and Stings / Q000276:immunology / Q000662:veterinary*; D007781:Lactoferrin / Q000276:immunology / Q000378:metabolism*; D008407:Mast Cells / Q000378:metabolism*; D012871:Skin Diseases / Q000276:immunology / Q000378:metabolism / Q000662:veterinary*
chemical_list: D007781:Lactoferrin